Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults-Reference-Cited by-同舟云学术

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults

Published:1997-01 Issue:9046 Volume:349 Page:155-159
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Cohen Dani,Ashkenazi Shai,Green Manfred S,Gdalevich Michael,Robin Guy,Slepon Raphael,Yavzori Miri,Orr Nadav,Block Colin,Ashkenazi Isaac,Shemer Joshua,Taylor David N,Hale Thomas L,Sadoff Jerald C,Pavliakova Danka,Schneerson Rachel,Robbins John B

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Shigellosis;Keusch,1991

2. A prospective epidemiologic study of shigellosis: implications for the new Shigella vaccines;Green;Isr J Med Sci,1987

3. Reduction of transmission of shigellosis by control of house flies (Musca domestica);Cohen;Lancet,1991

4. Dysentery, not watery diarrhoea, is associated with stunting in Bangladeshi children;Henry;Hum Nutr Clin Nutr,1987

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge;Vaccine;2024-10

2. Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate;npj Vaccines;2024-01-02

3. Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy;The Lancet Infectious Diseases;2023-12

4. Comparison of Shigella GMMA and glycoconjugate four-component formulations in animals;Frontiers in Molecular Biosciences;2023-11-16

5. Further characterization of Shigella-specific (memory) B cells induced in healthy volunteer recipients of SF2a-TT15, a Shigella flexneri 2a synthetic glycan-based vaccine candidate;Frontiers in Immunology;2023-10-31